09/01/2011- Over 11,000 ubiquitylation sites were identified using Lucerna's Diglycyl-lysine monoclonal antibodies in Wagner et al., Mol Cell Proteomics, 2011.
08/23/2011- DFHBI fluorophore, described in Science 2011,333, 642-646, is now available for purchase at Lucerna, Inc.
08/01/2011- New formulation of Diglycyl-lysine monoclonal antibody that features improved stability and increased pull-down efficiency is now available.
07/01/2011- Lucerna, Inc. was selected as one of the finalists for the USAID Saving Lives At Birth - A Grand Challenge for Development competition.
05/01/2011- Bill & Melinda Gates Foundation awarded Lucerna, Inc. a Grand Challenge Exploration Grant to develop a simple sepsis test.
